
Climate, Natural Resources and Environment
GO-GRASS
GO-GRASS will develop a new circular and integrated agri-food system whose main application will be in grasslands and which will...
Polycystic Ovary Syndrome (PCOS) In Adolescent Girls And Young Women: Toward A Treatment Guided By Pathophysiology
Project dates
2021 - 2026
Website
Role of Zabala
Partner
Project led by
Fundació Sant Joan de Déu
17
partners
9
countries
6 M€
total budget
5
years
Polycystic Ovary Syndrome (PCOS) is the most prevalent chronic endocrine-metabolic disorder in women of reproductive age, affecting 5-10% of women worldwide. It is the most frequent cause of anovulatory subfertility, and it is also associated with lifelong co-morbidities such as type 2 diabetes, premature vascular aging, premenopausal cancer and anxiety/depression.
There is currently no approved treatment for PCOS in adolescent and young women, approximately 98% of whom are prescribed oral contraceptives (OCs) off-label. OCs do alleviate key symptoms, such hirsutism and menstrual irregularity, but do not revert the underlying pathophysiology, and patients remain at risk for post-treatment subfertility.
Previous studies by FSJD and Katholieke Universiteit Leuven have led to the identification of a treatment (SPIOMET) consisting of two “insulin sensitisers” (pioglitazone [PIO] and metformin [MET]) and a mixed anti-androgen and anti-mineralocorticoid (spironolactone [SPI], which also acts as a brown adipose tissue activator. However, these studies had some limitations that SPIOMET4HEALTH aims to overcome. The project will test a novel treatment consisting of SPIOMET in a single tablet (SPI, 50 mg; PIO, 7.5 mg and MET, 850 mg) administered daily, in combination with lifestyle measures. It aims at normalizing ovulation and endocrine-metabolic status through reduction of hepato-visceral fat excess.
SPIOMET4Health could change the current paradigm of PCOS treatment, as the new therapy will not only target the gonadotropic axis, but also the underlying pathophysiology. This strategy should also reduce the psychosocial impact and economic burden of PCOS on healthcare systems. SPIOMET4HEALTH can also become a preconception strategy to be followed by spontaneous ovulation/conception, normal pregnancy and a healthier next generation.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme, under grant agreement No. 899671.
“SPIOMET4Health is proposed by a consortium of the highest-profile groups working on PCOS in AYAs; this project offers the EU a unique opportunity to enable a robust attempt to generate medical benefits for patients with PCOS, and to reduce the psycho-social and economic burden of PCOS on health care systems across Europe and worldwide. ”
Laura Sesma
Senior R&D&I Consultant
Climate, Natural Resources and Environment
GO-GRASS will develop a new circular and integrated agri-food system whose main application will be in grasslands and which will...
Health, Agri-food and Bioeconomy
BOW explores and consolidates a technology capable of endowing superparamagnetic nanodevices with the capabilities of extracellular vesicles (EVs) by "dressing"...
Digitisation
FIWARE FINODEX (Future Internet Open Data Expansion) is a European business incubator and accelerator.
News
Opinion
SECURITY R&D PROJECTS
Private: Jorge Lorente
R&I Consultant
Publication
KAILA
In Kaila, our smart platform, we have developed a definitive Horizon Europe calendar, the only one that includes all the call dates of the new Framework Programme. Download it now!
The important thing is not to keep moving, but rather to know in which direction to go. Our 37% success rate proves that we know how to guide our clients.
Our compass is our clients; our mission is to solve their problems, guiding them so that innovation becomes their key to competitiveness.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.